| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | - | - | - | 14 |
| Cost of goods sold | - | - | - | 7 |
| Gross profit | - | - | - | 7 |
| Research and development | 17,457 | 21,151 | 19,435 | 19,004 |
| Selling, general and administrative | 5,237 | 4,928 | 5,324 | 4,797 |
| Total operating expenses | 22,694 | 26,079 | 24,759 | 23,801 |
| Loss from operations | -22,694 | -26,079 | -24,759 | -23,794 |
| Interest income, net | 166 | 226 | 503 | 947 |
| Change in fair value of notes payable | 1,868 | 1,673 | 283 | 2,610 |
| Change in fair value of warrant liabilities | 21,201 | 348 | -825 | -2,293 |
| Other expense, net | -6 | -15 | -21 | -9 |
| Total other income (expense), net | -22,909 | -1,810 | 1,024 | 621 |
| Net loss and comprehensive loss | -45,603 | -27,889 | -23,735 | -23,173 |
| Net loss attributable to common stockholders | -45,603 | -27,889 | -23,735 | -23,173 |
| Earnings per share, basic, total | -0.71 | -0.57 | -0.49 | -0.48 |
| Earnings per share, diluted, total | -0.71 | -0.57 | -0.49 | -0.48 |
| Weighted average number of shares outstanding, basic, total | 64,652,953 | 49,042,926 | 48,865,468 | 47,973,951 |
| Weighted average number of shares outstanding, diluted, total | 64,652,953 | 49,042,926 | 48,865,468 | 47,973,951 |
FRACTYL HEALTH, INC. (GUTS)
FRACTYL HEALTH, INC. (GUTS)